ArticleJHEP reports : innovation in hepatology2026

Treatment response to bulevirtide is linked to amelioration of portal hypertension in patients with chronic hepatitis D.

Lisa Sandmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.